| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 664.102 | 814.825 | 460.065 | 48.081 | 36.933 | 61.866 | 77.060 | 42.729 | 35.626 | 7.602 |
| Total Income - EUR | 664.379 | 815.078 | 460.141 | 50.821 | 37.221 | 62.158 | 77.092 | 42.935 | 35.630 | 7.602 |
| Total Expenses - EUR | 617.284 | 749.419 | 442.262 | 47.632 | 36.481 | 56.571 | 70.854 | 38.169 | 30.709 | 18.384 |
| Gross Profit/Loss - EUR | 47.095 | 65.659 | 17.879 | 3.189 | 739 | 5.587 | 6.238 | 4.766 | 4.921 | -10.782 |
| Net Profit/Loss - EUR | 39.537 | 55.154 | 15.018 | 2.684 | 370 | 4.579 | 5.483 | 4.346 | 4.618 | -10.782 |
| Employees | 6 | 3 | 3 | 1 | 3 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Fytovital Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 986 | 572 | 0 | 0 | 0 | 0 | 1.956 | 2.306 | 1.707 | 13.341 |
| Current Assets | 215.976 | 306.552 | 283.665 | 141.970 | 20.574 | 22.218 | 25.641 | 24.279 | 32.805 | 8.939 |
| Inventories | 80.732 | 136.464 | 0 | 4.534 | 0 | 3.270 | 107 | 136 | 1.005 | 4.940 |
| Receivables | 134.353 | 168.644 | 282.553 | 137.043 | 20.226 | 18.788 | 25.376 | 24.101 | 31.725 | 3.909 |
| Cash | 892 | 1.444 | 1.112 | 394 | 348 | 160 | 157 | 43 | 75 | 90 |
| Shareholders Funds | 89.935 | 55.207 | 15.071 | 2.736 | 3.053 | 7.574 | 5.532 | 4.395 | 9.000 | -1.833 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 127.027 | 251.916 | 268.594 | 139.235 | 17.522 | 14.645 | 22.065 | 22.190 | 25.513 | 24.956 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4633 - 4633" | |||||||||
| CAEN Financial Year |
4633
|
|||||||||
Comments - Fytovital Srl